ACRS
Aclaris Therapeutics, Inc.Closed3.47−0.13 −3.61%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 3.39 −2.42%
Open
3.65
Prev close
3.60
Day range
3.413.65
52-week range
1.746.60
Volume
3.44M1.28×
Mkt cap
510.78M
P/E ttm
—
Fwd P/E
-4.41
EPS ttm
-0.5800
Div yield
0.00%
Earnings
Aug 6, 2026
From 52w high
−47.42%
ACRS earnings and estimates
ACRS Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 5
Before the open · estimated
EPS consensus
$−0.17
range −0.21 – −0.14
EPS growth vs year ago
−37.5%
year ago −0.12
Revenue consensus
$1.30M
−60.7% vs year ago
Options-implied move
—
no expiry soon after the report
Past 4 reactions
±2.9%
average move · beat 3 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 6, 2026 BMO | −0.15 | −0.16 | +6.25% | $1.63M | −4.2% | −8.2% |
| Mar '26 | May 7, 2026 BMO | −0.15 | −0.16 | +3.67% | $2.00M | +1.7% | +6.5% |
| Dec '25 | Feb 26, 2026 BMO | −0.16 | −0.14 | −17.07% | $1.29M | −5.4% | −6.3% |
| Sep '25 | Nov 6, 2025 BMO | −0.12 | −0.14 | +14.29% | $3.30M | +0.4% | +6.6% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.17 | −0.21−0.14 | −37.5% | $1.30M | −60.7% | −0.17 0.0% | −0.17 +4.3% | 4 / 1 |
| Next quarter Dec 2026 | −0.17 | −0.25−0.13 | −8.8% | $1.43M | +10.7% | −0.17 0.0% | −0.17 −3.9% | 4 / 3 |
| Current year Dec 2026 | −0.64 | −0.74−0.54 | −21.5% | $6.34M | −19.0% | −0.64 0.0% | −0.66 +1.7% | 4 / 3 |
| Next year Dec 2027 | −0.79 | −1.53−0.40 | −22.3% | $5.34M | −15.8% | −0.79 0.0% | −0.83 +5.0% | 4 / 4 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.16 | −0.17−0.15 | 5 | 0 / 0 |
| Dec 2026 | −0.16 | −0.17−0.14 | 5 | 0 / 0 |
| Mar 2027 | −0.16 | −0.18−0.14 | 4 | 0 / 0 |
| Jun 2027 | −0.15 | −0.19−0.12 | 4 | 0 / 0 |
| Sep 2027 | −0.16 | −0.20−0.09 | 4 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −0.62 | −0.65−0.60 | 5 | 0 / 0 |
| Dec 2027 | −0.65 | −0.78−0.43 | 5 | 0 / 0 |
| Dec 2028 | −0.66 | −0.84−0.35 | 3 | 0 / 0 |
| Dec 2029 | −0.74 | −0.89−0.56 | 3 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.